FDA Approved Indications for this Orphan Drug:For the use of Acetadote(registered TM) Injection, administered intravenously within 8 to 10 hours after ingestion of a potentially heptotoxic quantity of acetaminophen, to prevent or lessen hepatic injur
FDA Marketing Approval issued as of:
Cumberland Pharmaceuticals, Inc.
FDA Designation Date:
FDA Drug Designation:
For the intravenous treatment of moderate to severe acetaminophen overdose